Beam Therapeutics (BEAM) Earnings Date, Estimates & Call Transcripts $24.01 +0.71 (+3.05%) Closing price 04:00 PM EasternExtended Trading$24.03 +0.02 (+0.08%) As of 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Beam Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 6Before Market OpensEstimatedActual EPS (Feb. 25) -$1.09 Beat By $0.16 Consensus EPS (Feb. 25) -$1.25 Beam Therapeutics issued Q4 2024 earnings on February 25, 2025, reporting an EPS of -$1.09, which topped the consensus estimate of -$1.25 by $0.16. Quarterly revenue fell 90.5% year-over-year to $30 million, above the consensus estimate of $16.47 million. With a trailing EPS of -$4.58, Beam Therapeutics' earnings are expected to grow next year, from ($4.57) to ($4.27) per share. BEAM Upcoming EarningsBeam Therapeutics' next earnings date is estimated for Tuesday, May 6, 2025, based off prior year's reporting schedules. Get Beam Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Beam Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBEAM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BEAM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Beam Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20254-$1.20-$0.90-$1.05Q2 20254-$1.23-$0.90-$1.03Q3 20254-$1.22-$0.90-$1.02Q4 20254-$1.24-$0.86-$1.03FY 202516-$4.89-$3.56-$4.13Q1 20261-$0.83-$0.83-$0.83Q2 20261-$0.83-$0.83-$0.83Q3 20261-$0.83-$0.83-$0.83Q4 20261-$0.81-$0.81-$0.81FY 20264($3.30)($3.30)($3.30) Remove Ads Beam Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/6/2025(Estimated)-------2/25/2025Q4 2024-$1.25-$1.09+$0.16-$1.09$16.47M$30.00M11/5/2024Q3 2024-$1.16-$1.17 -$0.01-$1.17$14.52M$14.30M8/6/2024Q2 2024-$1.13-$1.11+$0.02-$1.11$14.18M$11.80M5/7/2024Q1 2024-$1.42-$1.21+$0.21-$1.21$17.09M$7.40M2/27/2024Q4 2023-$0.69$1.73+$2.42$1.73$34.16M$316.20M11/8/2023Q3 2023-$1.33-$1.22+$0.11-$1.22$17.09M$17.20M8/8/2023Q2 2023-$1.42-$1.08+$0.34-$1.08$17.32M$20.12M5/10/2023Q1 2023-$1.36-$1.33+$0.03-$1.33$14.41M$24.21M Beam Therapeutics Earnings - Frequently Asked Questions When is Beam Therapeutics's earnings date? Beam Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 6th, 2025 based off last year's report dates. Learn more on BEAM's earnings history. Did Beam Therapeutics beat their earnings estimates last quarter? In the previous quarter, Beam Therapeutics (NASDAQ:BEAM) reported ($1.09) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.25) by $0.16. Learn more on analysts' earnings estimate vs. BEAM's actual earnings. How much revenue does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded annual revenue of $63.52 million. How much profit does Beam Therapeutics generate each year? Beam Therapeutics (NASDAQ:BEAM) has a recorded net income of -$132.53 million. BEAM has generated -$4.58 earnings per share over the last four quarters. What is Beam Therapeutics's EPS forecast for next year? Beam Therapeutics's earnings are expected to grow from ($4.57) per share to ($4.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies PCVX Earnings QGEN Earnings ROIV Earnings RVMD Earnings LNTH Earnings LEGN Earnings TGTX Earnings BBIO Earnings AXSM Earnings BPMC Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles After Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss DigitalOcean Rides Cloud Wave and AI Hype to Strong EarningsPrice Targets on NVIDIA Rise in Front of Earnings Remove Ads This page (NASDAQ:BEAM) was last updated on 3/24/2025 by MarketBeat.com Staff From Our PartnersThis could put Trump on new $100 billAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
